We are live on
!
Find out more
Artisan Partners Portfolio holdings
AUM
$63.1B
Turnover
26.74%
1-Year Est. Return
35.51%
This Fund
S&P 500
This Quarter
Est. Return
-13.72%
1 Year Est. Return
+35.51%
3 Year Est. Return
+129.08%
5 Year Est. Return
+159.14%
10 Year Est. Return
+803.1%
AUM
$44.3B
AUM Growth
-$8.25B
(-16%)
Cap. Flow
-$195M
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
27.57%
Holding
315
New
45
Increased
90
Reduced
136
Closed
44
Avg Time Held Equity + Options
2.1
years
Top 10 Avg Time Held Equity + Options
2.5
years
Top 20 Avg Time Held Equity + Options
2.3
years
Avg Time Held Equity only
2.1
years
Top 10 Avg Time Held Equity only
2.5
years
Top 20 Avg Time Held Equity only
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Willis Towers Watson
WTW
|
+$616M |
| 2 |
AGN
Allergan plc
AGN
|
+$520M |
| 3 |
Meta Platforms (Facebook)
META
|
+$518M |
| 4 |
Agilent Technologies
A
|
+$381M |
| 5 |
NXP Semiconductors
NXPI
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LKQ Corp
LKQ
|
+$433M |
| 2 |
Canadian Pacific Kansas City
CP
|
+$430M |
| 3 |
NBL
Noble Energy, Inc.
NBL
|
+$419M |
| 4 |
Johnson & Johnson
JNJ
|
+$362M |
| 5 |
Salesforce
CRM
|
+$279M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.42% |
| 2 | Technology | 19.49% |
| 3 | Healthcare | 16.76% |
| 4 | Communication Services | 14.64% |
| 5 | Consumer Discretionary | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Equinix
EQIX
$98B
| $25.6M | 0.06% |
72,633
+27,198
| +60% | +$10.6M |
2018 Q3
1 quarter
|
|
|
ABMD
202
DELISTED
Abiomed Inc
ABMD
| $25.3M | 0.06% |
+77,882
| New | +$27.1M |
2018 Q4
0 quarters
|
|
|
TRHC
203
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $25.1M | 0.06% |
392,986
+203,100
| +107% | +$14.4M |
2018 Q3
1 quarter
|
|
204
Ambev
ABEV
$50.4B
| $24.7M | 0.06% |
+6,300,995
| New | +$26.9M |
2018 Q4
0 quarters
|
|
205
Thermo Fisher Scientific
TMO
$253B
| $24.1M | 0.05% |
107,531
+81,537
| +314% | +$19.1M |
2018 Q2
2 quarters
|
|
206
DELISTED
Sage Therapeutics
SAGE
| $24M | 0.05% |
+250,431
| New | +$28.7M |
2018 Q4
0 quarters
|
|
207
DELISTED
Cubic Corporation
CUB
| $23.6M | 0.05% |
438,975
+64,016
| +17% | +$4.03M |
2016 Q4
8 quarters
|
|
208
Rogers Corp
ROG
$2.42B
| $23M | 0.05% |
232,129
-14,347
| -6% | -$1.72M |
2017 Q4
4 quarters
|
|
209
Ascendis Pharma A/S
ASND
$14.9B
| $23M | 0.05% |
366,947
+135,275
| +58% | +$8.5M |
2018 Q2
2 quarters
|
|
210
Dollar Tree
DLTR
$23.5B
| $22.7M | 0.05% |
+251,550
| New | +$21.2M |
2018 Q4
0 quarters
|
|
211
Revvity
RVTY
$17.1B
| $22.6M | 0.05% |
+287,389
| New | +$24.3M |
2018 Q4
0 quarters
|
|
212
Fortis
FTS
$28.4B
| $22.5M | 0.05% |
+675,600
| New | +$22.7M |
2018 Q4
0 quarters
|
|
213
CME Group
CME
$104B
| $21.1M | 0.05% |
112,387
-55,250
| -33% | -$10.2M |
2017 Q2
6 quarters
|
|
|
XLRN
214
DELISTED
Acceleron Pharma
XLRN
| $21M | 0.05% |
483,167
-29,244
| -6% | -$1.46M |
2017 Q3
5 quarters
|
|
215
ICICI Bank
IBN
$108B
| $20.6M | 0.05% |
1,997,336
-929,659
| -32% | -$8.78M |
2015 Q3
13 quarters
|
|
216
NeoGenomics
NEO
$2.15B
| $18.7M | 0.04% |
1,480,487
-94,936
| -6% | -$1.41M |
2014 Q3
17 quarters
|
|
|
VRAY
217
DELISTED
ViewRay, Inc.
VRAY
| $18.3M | 0.04% |
3,008,677
-784,075
| -21% | -$5.88M |
2018 Q2
2 quarters
|
|
218
CAE Inc
CAE
$7.69B
| $17.5M | 0.04% |
952,354
+327,109
| +52% | +$6.22M |
2017 Q3
5 quarters
|
|
219
Microsoft
MSFT
$3.93T
| $17.3M | 0.04% |
170,197
+59,177
| +53% | +$6.34M |
2013 Q2
22 quarters
|
|
220
SBA Communications
SBAC
$19.9B
| $17M | 0.04% |
105,149
+18,321
| +21% | +$2.98M |
2018 Q3
1 quarter
|
|
|
WWE
221
DELISTED
World Wrestling Entertainment
WWE
| $16.8M | 0.04% |
+224,389
| New | +$16.9M |
2018 Q4
0 quarters
|
|
222
Dolby
DLB
$5.64B
| $16.7M | 0.04% |
269,420
+2,583
| +1% | +$174K |
2018 Q3
1 quarter
|
|
223
Ambarella
AMBA
$2.71B
| $16.1M | 0.04% |
461,536
-27,080
| -6% | -$959K |
2017 Q3
5 quarters
|
|
|
CPE
224
DELISTED
Callon Petroleum Company
CPE
| $15.9M | 0.04% |
245,021
-13,857
| -5% | -$1.34M |
2018 Q1
3 quarters
|
|
225
Floor & Decor
FND
$4.91B
| $15.4M | 0.03% |
594,335
-32,917
| -5% | -$961K |
2018 Q1
3 quarters
|
|
Similar funds
Artisan Partners's Q4 2018 Portfolio in Review
As of Q4 2018, Artisan Partners held 315 positions worth $44.3B, down 16% from $52.6B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Artisan Partners's Q4 2018 filing shows 45 new, 90 increased, 136 reduced and 44 closed positions. Its largest new stake was Willis Towers Watson: 4,115,223 shares worth $625M. The largest sale was LKQ Corp, an estimated $433M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Technology and Healthcare.
- Artisan Partners's largest Q4 2018 buy was Willis Towers Watson: 4,115,223 shares worth $625M.
- Artisan Partners added most to Allergan plc in Q4 2018, an estimated $520M increase.
- Artisan Partners's biggest Q4 2018 reduction was Canadian Pacific Kansas City, cutting an estimated $430M.
- Artisan Partners fully exited LKQ Corp in Q4 2018, selling an estimated $433M.
- Artisan Partners's ten largest holdings make up 28% of its $44.3B portfolio in Q4 2018.
- Artisan Partners opened 45 new positions and closed 44 in Q4 2018.
- Artisan Partners's portfolio value fell 16% quarter-over-quarter to $44.3B.
Based on Artisan Partners's 13F filing for Q4 2018, filed 12 Feb 2019.